Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 35, Issue , 2017, Pages S114-S121

  Carreira, Patricia E ^a   Carmona, Loreto ^b   Joven, Beatriz E ^a   Loza, Estibaliz ^b   Andreu, José Luis ^c   Riemekasten, Gabriela ^d   Vettori, Serena ^e   Allanore, Yannick ^f   Balbir Gurman, Alexandra ^g   Airò, Paolo ^h   Walker, Ulrich A ⁱ   Damjanov, Nemanja ^j   Ananieva, Lidia P ^k   Rednic, Simona ^l   Czirják, László ^m   Distler, Oliver ⁿ   Farge, Dominique ^o   Hesselstrand, Roger ^p   Corrado, Ada ^q   Caramaschi, Paola ^r   Tikly, Mohammed ^s   Matucci Cerinic, Marco ^t   more..

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Instituto de Salud Musculoesquelética InMusc Calle Hilarión Eslava   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d UNIVERSITY OF LÜBECK   (Germany)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f Institut Cochin   (France)

^g RAMBAM MEDICAL CENTER   (Israel)

^h SPEDALI CIVILI   (Italy)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^j UNIVERSITY OF BELGRADE   (Serbia)

^k V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^l IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^m UNIVERSITY OF PÉCS   (Hungary)

ⁿ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^o SAINT LOUIS HOSPITAL   (France)

^p LUND UNIVERSITY   (Sweden)

^q UNIVERSITY OF FOGGIA   (Italy)

^r UNIVERSITY HOSPITAL OF VERONA   (Italy)

^s UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^t UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

Pulmonary arterial hypertension; Right heart catheterisation; Systemic sclerosis

Indexed keywords

ANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FINGER ULCER; HEART BLOCK; HEART CATHETERIZATION; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS; SYSTOLIC PULMONARY ARTERY PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PULMONARY ARTERY; STATISTICAL MODEL; SYSTOLE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC; SYSTOLE;

EID: 85031665405     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. AVOUAC J, AIRO P, MEUNE C et al.: Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010; 37: 2290-8
2. RUBIO-RIVAS M, ROYO C, SIMEON CP, CORBELLA X, FONOLLOSA V: Mortality and survival in systemic sclerosis: Systematic review and meta-analysis. Semin Arthritis Rheum 2014; 44: 208-19
3. STEEN VD, MEDSGER TA: Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4
4. GIORDANO N, MONTELLA A, CORALLO C et al.: Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients. Clin Exp Rheumatol 2015; 33 (Suppl. 91): S182-9
5. Proceedings of the 4th World Symposium on Pulmonary Hypertension, February 2008, Dana Point, California, USA. J Am Coll Cardiol 2009; 54 (Suppl.): S1-117
6. POPE JE, LEE P, BARON M et al.: Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 2005; 32: 1273-8
7. HSU VM, MOREYRA AE, WILSON AC et al.: Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 2008; 35: 458-65
8. FISCHER A, SWIGRIS JJ, BOLSTER MB et al.: Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. Clin Exp Rheumatol 2014; 32 (Suppl. 86): S109-14
9. IUDICI M, CODULLO V, GIUGGIOLI D et al.: Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort. Clin Exp Rheumatol 2013; 31 (Suppl. 76): S31-6
10. CHANG B, SCHACHNA L, WHITE B, WIGLEY FM, WISE RA: Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol 2006; 33: 269-74
11. MUKERJEE D, ST GEORGE D, COLEIRO B et al.: Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93
12. COX SR, WALKER JG, COLEMAN M et al.: Isolated pulmonary hypertension in scleroderma. Intern Med J 2005; 35: 28-33
13. STEEN V, MEDSGER TA, Jr: Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48: 516-22
14. NIHTYANOVA SI, SCHREIBER BE, ONG VH et al.: Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 2014; 66: 1625-35
15. LEFEVRE G, DAUCHET L, HACHULLA E et al.: Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum 2013; 65: 2412-23
16. MEUNE C, AVOUAC J, AIRO P et al.: Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum 2011; 63: 2790-6
17. HACHULLA E, LAUNAY D, MOUTHON L et al.: Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest 2009; 136: 1211-9
18. DORFMULLER P, HUMBERT M, PERROS F et al.: Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007; 38: 893-902
19. PAPAGORAS C, ACHENBACH K, TSIFETAKI N, TSIOURIS S, FOTOPOULOS A, DROSOS AA: Heart involvement in systemic sclerosis: a combined echocardiographic and scintigraphic study. Clin Rheumatol 2014; 33: 1105-11
20. HACHULLA E, GRESSIN V, GUILLEVIN L et al.: Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792-800
21. FOX BD, SHIMONY A, LANGLEBEN D et al.: High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J 2013; 42: 1083-91
22. COGHLAN G: Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Eur Respir J 2013; 42: 888-90
23. HUMBERT M, YAICI A, DE GROOTE P et al.: Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 2011; 63: 3522-30
24. LE PAVEC J, GIRGIS RE, LECHTZIN N et al.: Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. Arthritis Rheum 2011; 63: 2456-64
25. AVOUAC J, HUSCHER D, FURST DE, OPITZ CF, DISTLER O, ALLANORE Y: Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis. Ann Rheum Dis 2014; 73: 191-7
26. HOEPER MM, BOGAARD HJ, CONDLIFFE R et al.: Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62 (Suppl.): D42-50
27. SOUKUP T, PUDIL R, KUBINOVA K et al.: Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre. Rheumatology 2016; 55: 109-14
28. COGHLAN JG, DENTON CP, GRUNIG E et al.: Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2014; 73: 1340-9
29. WALKER UA, TYNDALL A, CZIRJAK L et al.: Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754-63
30. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90
31. LeROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5
32. VALENTINI G, BENCIVELLI W, BOMBARDIERI S et al.: European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003; 62: 901-3
33. CHATTERJEE S: Pulmonary hypertension in systemic sclerosis. Semin Arthritis Rheum 2011; 41: 19-37
34. PIERONI M, DE SANTIS M, ZIZZO G et al.: Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 2014; 43: 526-35
35. RANQUE B, BEREZNE A, LE-GUERN V et al.: Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. Scand J Rheumatol 2010; 39: 498-505
36. ROSATO E, MAIONE S, VITARELLI A et al.: Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables. Rheumatol Int 2009; 29: 913-9
37. CASTRO CE, LYAPIN A, PATTATHAN M, NEGRIN J, MUKHERJEE D: Prevalence and predictors of left ventricular diastolic dysfunction in a Hispanic patient population. Int J Angiol 2013; 22: 229-34
38. STEEN VD, MEDSGER TA, Jr: Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000; 133: 600-3
39. MULLER-LADNER U, DISTLER O, IBBAMANNESCHI L, NEUMANN E, GAY S: Mechanisms of vascular damage in systemic sclerosis. Autoimmunity 2009; 42: 587-95
40. HACHULLA E, DE GROOTE P, GRESSIN V et al.: The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009; 60: 1831-9
41. HACHULLA E, CLERSON P, AIRO P et al.: Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population. Rheumatology 2015; 54: 1262-9
42. HSU VM, CHUNG L, HUMMERS LK et al.: Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Semin Arthritis Rheum 2014; 44: 55-62
43. MEIER FM, FROMMER KW, DINSER R et al.: Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012; 71: 1355-60
44. van den HOOGEN F, KHANNA D, FRANSEN J et al.: 2013 classification criteria for systemic sclerosis: an American college of rheumatology/ European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747-55
45. KARIMIFAR M, HASHEMI H, KAZIZADEH A: A case of sine scleroderma with parenchymal lung disease. Adv Biomed Res 2014; 3: 39
46. MARANGONI RG, ROCHA LF, DEL RIO AP, YOSHINARI NH, MARQUES-NETO JF, SAMPAIO-BARROS PD: Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort. Rheumatology 2013; 52: 1520-4
47. SIMEON-AZNAR CP, FONOLLOSA-PLA V, TOLOSA-VILELLA C et al.: Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Reum 2012; 41: 789-800
48. SHAH AA, WIGLEY FM, HUMMERS LK: Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol 2010; 37: 98-104
49. SILVER RM, BOGATKEVICH G, TOURKINA E, NIETERT PJ, HOFFMAN S: Racial differences between blacks and whites with systemic sclerosis. Curr Opin Rheumatol 2012; 24: 642-8